| Glycyrrhizic-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Glycyrrhizic-acid | hsa00340 | Histidine metabolism | 4.52E-02 | 1 | O95954 | FTCD | More | |
| Glycyrrhizic-acid | hsa00514 | Other types of O-glycan biosynthesis | 3.20E-02 | 2 | O15294, Q9NY28 | OGT, GALNT8 | More | |
| Glycyrrhizic-acid | hsa00564 | Glycerophospholipid metabolism | 9.70E-03 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | |
| Glycyrrhizic-acid | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
| Glycyrrhizic-acid | hsa00920 | Sulfur metabolism | 2.29E-02 | 1 | Q16762 | TST | More | |
| Glycyrrhizic-acid | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.20E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Glycyrrhizic-acid | hsa00982 | Drug metabolism - cytochrome P450 | 3.20E-02 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
| Glycyrrhizic-acid | hsa01100 | Metabolic pathways | 2.25E-02 | 7 | Q9Y259, Q13956, P49619, O95954, Q02318, Q9UBX8, P35573 | CHKB, PDE6H, DGKG, FTCD, CYP27A1, B4GALT6, AGL | More | |
| Glycyrrhizic-acid | hsa01524 | Platinum drug resistance | 3.62E-02 | 4 | Q13489, P98170, P78417, P43246 | BIRC3, BIRC4, GSTO1, MSH2 | More | |
| Glycyrrhizic-acid | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Glycyrrhizic-acid | hsa03320 | PPAR signaling pathway | 1.62E-02 | 2 | Q13133, Q02318 | NR1H3, CYP27A1 | More | |
| Glycyrrhizic-acid | hsa04014 | Ras signaling pathway | 4.38E-02 | 5 | P20827, P49767, Q14644, P0DP23, P62873 | EFNA1, VEGFC, RASA3, CALM1, GNB1 | More | |
| Glycyrrhizic-acid | hsa04110 | Cell cycle | 3.57E-02 | 3 | Q9UBD5, P06493, P33981 | ORC3, CDK1, TTK | More | |
| Glycyrrhizic-acid | hsa04122 | Sulfur relay system | 2.29E-02 | 1 | Q16762 | TST | More | |
| Glycyrrhizic-acid | hsa04371 | Apelin signaling pathway | 9.26E-03 | 5 | P62873, Q13485, P84022, Q16566, P0DP23 | GNB1, SMAD4, SMAD3, CAMK4, CALM1 | More | |
| Glycyrrhizic-acid | hsa04512 | ECM-receptor interaction | 2.00E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | |
| Glycyrrhizic-acid | hsa04514 | Cell adhesion molecules | 3.82E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | |
| Glycyrrhizic-acid | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
| Glycyrrhizic-acid | hsa04611 | Platelet activation | 2.25E-04 | 4 | P08514, Q15746, Q8WYR1, P07359 | ITGA2B, MYLK, PIK3R5, GP1BA | More | |
| Glycyrrhizic-acid | hsa04612 | Antigen processing and presentation | 4.78E-02 | 6 | P48382, P26715, P26717, Q13241, O43908, P01375 | RFX5, KLRC1, KLRC2, KLRD1, KLRC4, TNF | More | |
| Glycyrrhizic-acid | hsa04613 | Neutrophil extracellular trap formation | 9.55E-03 | 4 | P16109, Q99878, P08514, P07359 | SELP, H2AC14, ITGA2B, GP1BA | More | |
| Glycyrrhizic-acid | hsa04621 | NOD-like receptor signaling pathway | 2.27E-02 | 9 | Q9H1Y0, P43490, O00463, Q05823, P01375, P49913, P59665, P59666, P12838 | ATG5, PBEF1, TRAF5, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
| Glycyrrhizic-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 1.25E-02 | 8 | P01375, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | |
| Glycyrrhizic-acid | hsa04657 | IL-17 signaling pathway | 3.62E-02 | 4 | P08238, Q07955, Q9UJX4, P04141 | HSP90AB1, SFRS1, ANAPC5, CSF2 | More | |
| Glycyrrhizic-acid | hsa04744 | Phototransduction | 5.92E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
| Glycyrrhizic-acid | hsa04921 | Oxytocin signaling pathway | 4.91E-02 | 2 | Q15746, Q8WYR1 | MYLK, PIK3R5 | More | |
| Glycyrrhizic-acid | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.33E-02 | 4 | P84022, Q13485, Q12778, P49767 | SMAD3, SMAD4, FOXO1, VEGFC | More | |
| Glycyrrhizic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Glycyrrhizic-acid | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Glycyrrhizic-acid | hsa05034 | Alcoholism | 4.38E-02 | 5 | Q16566, P0DP23, P62873, O60814, P68431 | CAMK4, CALM1, GNB1, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Glycyrrhizic-acid | hsa05133 | Pertussis | 2.15E-03 | 4 | P11215, P0DP23, P23528, P0C0L4 | ITGAM, CALM1, CFL1, C4A | More | |
| Glycyrrhizic-acid | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Glycyrrhizic-acid | hsa05144 | Malaria | 3.76E-03 | 6 | P60033, P69905, P68871, P01375, P35443, P26718 | CD81, HBA2, HBB, TNF, THBS4, KLRK1 | More | |
| Glycyrrhizic-acid | hsa05150 | Staphylococcus aureus infection | 1.61E-04 | 9 | P21730, P21462, O75015, Q14532, P16109, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, KRT32, SELP, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | |
| Glycyrrhizic-acid | hsa05200 | Pathways in cancer | 6.17E-03 | 12 | Q13751, P08238, P43246, P84022, Q13485, Q13489, P98170, P49767, Q12778, P62873, P78417, P0DP23 | LAMB3, HSP90AB1, MSH2, SMAD3, SMAD4, BIRC3, BIRC4, VEGFC, FOXO1, GNB1, GSTO1, CALM1 | More | |
| Glycyrrhizic-acid | hsa05231 | Choline metabolism in cancer | 2.00E-02 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | |
| Glycyrrhizic-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
